Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 Fat Loss Protocol: Comparison

Injection Frequency 2–3 times weekly 2–3 times daily CJC-1295 DAC requires far fewer injections due to 6–8 day half-life vs minutes for non-DAC variants Dose Per Injection 200–300mcg 100–200mcg per dose 200–300mcg per dose DAC modification allows higher single

This comparison does not assign a generated winner or score.

  • Injection Frequency
  • 2–3 times weekly
  • 2–3 times daily
  • CJC-1295 DAC requires far fewer injections due to 6–8 day half-life vs minutes for non-DAC variants
  • Dose Per Injection
  • 200–300mcg
  • 100–200mcg per dose
  • 200–300mcg per dose
  • DAC modification allows higher single doses; non-DAC variants require lower per-dose amounts with higher frequency
  • Timing Requirement
  • 30–60 min pre-sleep
  • Pre-sleep + post-workout + fasted morning
  • DAC version simplifies compliance. One injection window vs three daily windows
  • GH Pulse Pattern
  • Amplifies endogenous pulses (maintains pulsatility)
  • Stimulates GH release directly (can blunt natural pulses with chronic use)
  • GHRH analogs (CJC variants) preserve natural pulsatile rhythm; GHRPs like ipamorelin risk desensitisation
  • Insulin Sensitivity Impact
  • Neutral to slightly positive (GH-mediated)
  • Neutral to slightly positive
  • Neutral
  • All three maintain insulin sensitivity better than exogenous GH; no significant difference between compounds
  • Fat Loss Mechanism
  • GH → HSL activation → lipolysis during fasted state
  • Mechanism identical across all; difference is dosing convenience and natural pulse preservation
More references

Related material